• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The evolution and characterization of influenza A(H7N9) virus under the selective pressure of peramivir

tetano

Editor, Senior Moderator
Virology. 2019 Aug 6;536:58-67. doi: 10.1016/j.virol.2019.08.004. [Epub ahead of print]
[h=1]The evolution and characterization of influenza A(H7N9) virus under the selective pressure of peramivir.[/h] Ge Y[SUP]1[/SUP], Chi Y[SUP]2[/SUP], Min X[SUP]3[/SUP], Zhao K[SUP]2[/SUP], Wu B[SUP]2[/SUP], Wu T[SUP]2[/SUP], Zhu X[SUP]2[/SUP], Shi Z[SUP]2[/SUP], Zhu F[SUP]2[/SUP], Cui L[SUP]4[/SUP].
[h=3]Author information[/h] 1 Institute of Pathogenic Microbiology, NHC Key Laboratories of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, 210009, China. Electronic address: geyiyue@163.com. 2 Institute of Pathogenic Microbiology, NHC Key Laboratories of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, 210009, China. 3 Department of Geriatric Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. 4 Institute of Pathogenic Microbiology, NHC Key Laboratories of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, 210009, China. Electronic address: lbcui@jscdc.cn.

[h=3]Abstract[/h] Human infection with H7N9 virus has provoked global public health concern due to the substantial morbidity and mortality. Neuraminidase inhibitors (NAIs) are used as first-line drugs to treat the infection. However, virus quasispecies can evolve rapidly under drug pressure, which may alter various biological characteristics of virus. Using an in vitro evolution platform and next-generation sequencing, we found the presence of peramivir led to changes to the dominant populations of the virus. Two important amino acid substitutions were identified in NA, I222T and H274Y, which caused reduced susceptibilities to oseltamivir or both oseltamivir and peramivir as confirmed by enzyme- and cell-based assays. The NA-H274Y variant showed decreased replicative fitness at the early stage of infection accompanied with impaired NA function. The quasispecies evolution of H7N9 virus and the potential emergence of these two variants should be closely monitored, which may guide the adjustment of antiviral strategies.
Copyright ? 2019 Elsevier Inc. All rights reserved.


[h=4]KEYWORDS:[/h] Evolution; H7N9; Influenza virus; Mutation; Neuraminidase; Peramivir; Quasispecies; Selective pressure

PMID: 31400550 DOI: 10.1016/j.virol.2019.08.004
 
Back
Top Bottom